Jefferies Financial Group Raises Albemarle (NYSE:ALB) Price Target to $105.00

Albemarle (NYSE:ALB) had its price target increased by stock analysts at Jefferies Financial Group from $90.00 to $105.00 in a research report issued to clients and investors on Monday,MarketScreener reports. The firm presently has a “buy” rating on the specialty chemicals company’s stock. Jefferies Financial Group’s price target indicates a potential upside of 17.73% from the company’s previous close.

A number of other equities analysts also recently issued reports on ALB. HSBC increased their price objective on shares of Albemarle from $60.00 to $75.00 and gave the company a “hold” rating in a research note on Monday, September 22nd. Wall Street Zen raised shares of Albemarle from a “sell” rating to a “hold” rating in a research report on Saturday, August 16th. Deutsche Bank Aktiengesellschaft set a $74.00 target price on shares of Albemarle and gave the company a “hold” rating in a research report on Monday, August 4th. KeyCorp reissued a “sector weight” rating on shares of Albemarle in a research report on Wednesday, July 30th. Finally, Baird R W cut shares of Albemarle from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 29th. Four research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average target price of $87.68.

Albemarle Price Performance

Shares of ALB stock opened at $89.18 on Monday. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.31 and a quick ratio of 1.47. The company has a market capitalization of $10.50 billion, a P/E ratio of -9.55 and a beta of 1.65. The company’s 50-day simple moving average is $79.19 and its two-hundred day simple moving average is $68.70. Albemarle has a one year low of $49.43 and a one year high of $113.91.

Albemarle (NYSE:ALB) last issued its earnings results on Wednesday, July 30th. The specialty chemicals company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of ($0.83) by $0.94. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.23 billion. Albemarle had a negative net margin of 18.61% and a negative return on equity of 1.87%. The company’s revenue for the quarter was down 7.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.04 EPS. Albemarle has set its FY 2025 guidance at EPS. As a group, equities analysts anticipate that Albemarle will post -0.04 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Hantz Financial Services Inc. raised its holdings in shares of Albemarle by 10,050.0% during the second quarter. Hantz Financial Services Inc. now owns 406 shares of the specialty chemicals company’s stock worth $25,000 after purchasing an additional 402 shares during the last quarter. SJS Investment Consulting Inc. acquired a new stake in Albemarle during the first quarter valued at $32,000. CVA Family Office LLC grew its position in Albemarle by 7,257.1% during the second quarter. CVA Family Office LLC now owns 515 shares of the specialty chemicals company’s stock valued at $32,000 after buying an additional 508 shares during the period. National Pension Service grew its position in Albemarle by 74.5% during the first quarter. National Pension Service now owns 452 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 193 shares during the period. Finally, Costello Asset Management INC acquired a new stake in Albemarle during the first quarter valued at $36,000. Hedge funds and other institutional investors own 92.87% of the company’s stock.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.